EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus



Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus



Faseb Journal 24(7): 2583-2590



Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in the pathogenesis of a variety of autoimmune inflammatory diseases. Here, we investigated the role of MIF in the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM) using MIF(-/-) mice and a mouse model of streptozotocin (STZ)-induced NIDDM. Following single injection of STZ, MIF(+/+) BALB/c mice showed a significant increase in blood glucose levels, developed polyuria, and succumbed to disease. In contrast, no such increase in blood glucose was observed in MIF(-/-) BALB/c mice treated with STZ. These mice produced significantly less inflammatory cytokines and resistin as compared with MIF(+/+) mice and failed to develop clinical disease. Finally, oral administration of a small-molecule MIF antagonist, CPSI-1306, to outbred ICR mice following induction of NIDDM significantly lowered blood glucose levels in the majority of animals, which was also associated with a significant reduction in the levels of the proinflammatory cytokines IL-6 and TNF-alpha in the sera. Taken together, these results demonstrate that MIF is involved in the pathogenesis of NIDDM and is a therapeutic target to treat this disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 054215821

Download citation: RISBibTeXText

PMID: 20203087

DOI: 10.1096/fj.09-147066



Related references

Macrophage migration inhibitory factor is a potential therapeutic target in inflammation. Inflammation Research 52(Supplement 2): S 79, July, 2003

Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. Bmc Cancer 15(): 843-843, 2016

Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflammation & Allergy Drug Targets 6(3): 183-190, 2007

New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Internal Medicine Journal 35(7): 419-426, 2005

Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. Journal of Cellular Physiology 215(3): 665-675, 2007

Macrophage Migration Inhibitory Factor-A Potential Target for Diabetes Prevention?. American Journal of the Medical Sciences, 2018

Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis and Rheumatism 48(2): 291-299, 2003

Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis. Korean Journal of Internal Medicine 31(4): 634-642, 2016

Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer. Cytokine & Growth Factor Reviews 26(4): 451-461, 2016

Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?. Immunology and Cell Biology 81(5): 367-373, 2003

Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation. Journal of Infectious Diseases 212(10): 1677-1682, 2016

Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus. Gynecological Endocrinology 28(1): 76-79, 2012

Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus. Diabetic Medicine 27(2): 143-149, 2010

An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. Journal of Immunology 186(11): 6607-6616, 2011

Association of Macrophage Migration Inhibitory Factor Polymorphisms with Gestational Diabetes Mellitus in Han Chinese Women. Gynecologic and Obstetric Investigation 81(1): 84-89, 2015